EUVIMEDEUVIMED entdecken
VergleichsstudieBeobachtungsstudie

Long‐Term Clinical Outcomes of Biodegradable‐ Versus Durable‐Polymer‐Coated Everolimus‐Eluting Stents in Real‐World Post‐Marketing Study

Waiel Abusnina, Brian C Case, Cheng Zhang, Kalyan R Chitturi, Vaishnavi Sawant, Abhishek Chaturvedi, Dan Haberman, Lior Lupu, Jospeh A Sutton, Syed W Ali, Teshome Deksissa, Shreejana Pokharel und 7 weitere

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31292 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Waiel Abusnina und 18 weiteren Autor:innen. Beteiligte Einrichtung: Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Absorbable Implants, Everolimus, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Financial support was provided by the Boston Scientific Corporation., Boston Scientific Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long‐term clinical data on biodegradable‐polymer (BP) drug‐eluting stents (DES) are limited. The objective of this study was to assess the long‐term safety and efficacy of the BP‐DES SYNERGY compared to XIENCE V, a durable‐polymer (DP)‐DES.

Methods

We compared patients treated with BP‐DES or DP‐DES at our center from 2008 to 2020. The primary outcome was major adverse cardiac events (MACE), defined as the composite of all‐cause death, Q‐wave myocardial infarction (MI), and target vessel revascularization (TVR). Secondary endpoints were all‐cause death, Q‐wave MI, target lesion revascularization (TLR), and stent thrombosis (ST).

Results

A total of 4255 patients underwent propensity‐score matching, and 380 patients from each cohort were matched. There was no significant difference between BP‐DES and DP‐DES concerning MACE (5‐year estimates: 21.6% vs. 26.6%, log‐rank p = 0.259). Furthermore, there was no difference in the TLR rate (5‐year estimates: 7.3% vs. 8.6%, log‐rank p = 0.781). All‐cause death (5‐year estimates: 13.6% vs. 12.9%, log‐rank p = 0.72) and Q‐wave MI (5‐year estimates: 0.53% vs. 1.7%, log‐rank p = 0.427) were also comparable between the two groups. Of note, the rate of very late ST was very low and similar between the groups (5‐year estimates: 0.26% vs. 0.64%, log‐rank p = 0.698).

Conclusion

BP‐DES and DP‐DES demonstrate similar safety and efficacy at 5‐year follow‐up. Both can be used for the effective treatment of coronary artery disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Eluting StentsAbsorbable ImplantsEverolimusPercutaneous Coronary InterventionCoronary Artery DiseasePolymersCardiovascular AgentsHumansMaleFemaleAgedProsthesis DesignTime FactorsTreatment OutcomeMiddle AgedRisk FactorsRetrospective StudiesRisk AssessmentProduct Surveillance, Postmarketing

Stichwörter der Autor:innen

biodegradable polymercoronary artery diseasedrug‐eluting stentdurable polymereverolimus‐eluting stent

Substanzen

EverolimusPolymersCardiovascular Agents

Autor:innen und Institutionen

  • Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA.

ORCID-Profile: Lowell F Satler, Ron Waksman

Förderung

  • Financial support was provided by the Boston Scientific Corporation.
  • Boston Scientific Corporation

Zitieren

APA

Abusnina, W., Case, B. C., Zhang, C., Chitturi, K. R., Sawant, V., Chaturvedi, A., Haberman, D., Lupu, L., Sutton, J. A., Ali, S. W., Deksissa, T., Pokharel, S., Ozturk, S. T., Margulies, A., Ben-Dor, I., Hashim, H. D., Satler, L. F., Garcia-Garcia, H. M., & Waksman, R. (2025). Long‐Term Clinical Outcomes of Biodegradable‐ Versus Durable‐Polymer‐Coated Everolimus‐Eluting Stents in Real‐World Post‐Marketing Study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31292

Vancouver

Abusnina W, Case BC, Zhang C, Chitturi KR, Sawant V, Chaturvedi A, et al. Long‐Term Clinical Outcomes of Biodegradable‐ Versus Durable‐Polymer‐Coated Everolimus‐Eluting Stents in Real‐World Post‐Marketing Study. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31292

BibTeX
@article{Abusnina2025,
  author = {Abusnina, Waiel and Case, Brian C and Zhang, Cheng and Chitturi, Kalyan R and Sawant, Vaishnavi and Chaturvedi, Abhishek and Haberman, Dan and Lupu, Lior and Sutton, Jospeh A and Ali, Syed W and Deksissa, Teshome and Pokharel, Shreejana and Ozturk, Sevket T and Margulies, Adrian and Ben-Dor, Itsik and Hashim, Hayder D and Satler, Lowell F and Garcia-Garcia, Hector M and Waksman, Ron},
  title = {Long‐Term Clinical Outcomes of Biodegradable‐ Versus Durable‐Polymer‐Coated Everolimus‐Eluting Stents in Real‐World Post‐Marketing Study},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31292}
}
Kostenlos starten →